Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fachinger, DE

Georg Fachinger, Limburg DE

Patent application numberDescriptionPublished
20100269500DEVICE FOR SUPPLYING PRESSURE TO AN ACTUATION UNIT OF A MOTOR VEHICLE BRAKE SYSTEM AND METHOD FOR CONTROLLING SAID DEVICE - A device for supplying pressure to an actuation unit of a vehicle brake system, in particular to a vehicle brake system of the ‘brake-by-wire’ type, comprising a pneumatic motor-and-pump assembly with a pump and a motor driving the pump, wherein the motor-and-pump assembly is controlled by an electronic control unit depending on a pressure level or pressure difference in a pneumatic brake booster of the actuation unit, with the pressure level in a chamber or a difference in pressure between two chambers of the brake booster being detected by means of a sensor. In order to maintain the availability of the service brake function as high as possible and to obtain a maximum possible redundancy, the control unit, used to control the motor-and-pump assembly comprises a logic module and a power module, which are arranged separately of each other.10-28-2010

Patent applications by Georg Fachinger, Limburg DE

Georg Fachinger, Limburg/lahn DE

Patent application numberDescriptionPublished
20090230762Brake System for Motor Vehicles - Disclosed is a brake system for a motor vehicle having actuating unit (09-17-2009

Thomas Fachinger, Niederheimbach DE

Patent application numberDescriptionPublished
20090306378PROCESS FOR PREPARING AMINOCROTONYLAMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES - The invention relates to an improved process for preparing aminocrotonylamino-substituted quinazoline derivatives of general formula (I) wherein the groups R12-10-2009
20110087021NOVEL PREPARATION PROCESS - A process for preparing compounds of the formula (I)04-14-2011

Vicky Fachinger, Bad Soden DE

Patent application numberDescriptionPublished
20080305128TREATMENT OF PRDC IN PIGS - The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.12-11-2008
20090010954PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD - The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.01-08-2009
20100129397EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS - The present invention relates to the use of porcine circovirus type 2 (PCV2) antigen and 05-27-2010
20110052629METHODS OF REDUCING CONCOMITANT INFECTIONS IN PIGS WITH A PCV2 ANTIGEN - The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.03-03-2011
20110091499TREATMENT OF PIGS WITH PCV2 ANTIGENT - The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.04-21-2011
20110129495TREATMENT OF PRDC IN PIGS - The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.06-02-2011

Patent applications by Vicky Fachinger, Bad Soden DE

Vicky Fachinger, Ingelheim Am Rhein DE

Patent application numberDescriptionPublished
20090098158REDUCTION OF CONCOMITANT INFECTIONS IN PIGS BY THE USE OF PCV2 ANTIGEN - The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.04-16-2009